Darvish Nissim 4
4 · Chemomab Therapeutics Ltd. · Filed Mar 9, 2022
Insider Transaction Report
Form 4
Darvish Nissim
Director
Transactions
- Award
Option to Purchase American Depositary Shares
2022-03-07+6,820→ 6,820 totalExercise: $3.53Exp: 2032-03-07→ American Depositary Shares (6,820 underlying) - Award
Option to Purchase American Depositary Shares
2021-04-19+11,884→ 11,884 totalExercise: $27.26Exp: 2031-04-19→ American Depositary Shares (11,884 underlying)
Holdings
- 10,123
Option to Purchase American Depositary Shares
Exercise: $0.80Exp: 2026-10-27→ American Depositary Shares (10,123 underlying)
Footnotes (5)
- [F1]These options vest and become exercisable in their entirety on March 16, 2023.
- [F2]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F4]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
- [F5]The options reported in this row have all vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.